Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall tone indicates strong support for the article's findings, with many commenters citing specific data, such as the higher effectiveness of Moderna over Pfizer in Qatar, and emphasizing the importance of scientific evidence. Words like 'study,' 'efficacy,' and 'effectiveness,' as well as comparisons and questions about data validity, demonstrate a high level of interest and engagement while reflecting a focus on the impact of vaccine performance studies.
Most discussions support the findings that both mRNA vaccines are effective, with some highlighting the higher efficacy of Moderna.
Posts show high interest, referencing detailed data, comparisons, and expressing curiosity about vaccine performance over time.
Many individuals engage deeply, citing specific study results, criticizing or defending data accuracy, and discussing implications for public health.
The discussions could influence opinions on vaccine efficacy, but the overall focus seems to be on scientific debate rather than immediate policy change.
モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar https://t.co/4sWDfYEKBs https://t.co/7FnJHvvGPp
なんぼでも科学的根拠ありますけど 宮沢孝幸の主張には科学的根拠はないですけどね #デマ #1730万研究費不正 https://t.co/YE6rwB6h5E https://t.co/9L0mGSNIoT https://t.co/DVovp7cpHX https://t.co/vJPeBzB21B https://t.co/9UspsGOY0T https://t.co/9aOgX2glPD https://t.co/aRiooQ1xjV https://t.co/iMZhGscjXw
2/ ... ES SU DECISIÓN. EL FUNDAMENTO CIENTIFICO PARA COLOCAR TERCERA Y CUARTA DOSIS, ADEMAS DE EVIDENCIA. Las vacunas que con el tiempo han demostrado más eficacia son las ARNm es decir Pfizer y Moderna : en este estudio se compararon 193,000 personas https://t.co/g9V83LTugD
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM Avantage Moderna https://t.co/8ElG5eBJ2B
@Inconforme75 @BeatrizTalegon 173-https://t.co/httZqzdKfv 174-https://t.co/k1V1EmHScu 175-https://t.co/i8ziMTNoAF 176-https://t.co/gPONicElAy 177-https://t.co/EQr5G6bdwN 178-https://t.co/CpJgcG5fJf 179-https://t.co/1LE0in6bYz 180-https://t.co/2oRZE0z9Ea! 181-https://t.co/ghpODTbWP8 182-https://t.co/FDHnzNPfO3
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM https://t.co/JbQuykj6rv
This video examines the protection offered by COVID-19 vaccines versus natural infection in the Qatari population. Vaccine effectiveness peaks shortly after vaccination but declines over time, though protection against…
This video discusses the effects of prior infection and vaccination on protection against symptomatic Omicron infections, highlighting how different immunity forms influence COVID-19 severity.
@todomejorqnada @Farmaenfurecida Si quieres o necesitas más estudios, aquí te dejo unos cuantos más. Es evidencia global en estudios independientes: https://t.co/IlyWaz7oPj https://t.co/XQ6uhcixi7 https://t.co/Fl2S2jTD0K https://t.co/34oBseFWK2
@ShalomOnKaspa @FliesLordofthe @DrEricDing 1. Abu-Raddad LJ, Chemaitelly H, Bertollini R, National Study Group for COVID-19 Vaccination. Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar. N Engl J Med 2022; 386:799.
@Michaelwdunn68 @chrismartenson 1. Abu-Raddad LJ, Chemaitelly H, Bertollini R, National Study Group for COVID-19 Vaccination. Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar. N Engl J Med 2022; 386:799.
@unhoodwinked @DrNeilStone Pfizer placebo study for emergency authorization: https://t.co/29qaO3ZqiJ Pfizer long-term (6 month) study for normal approval: https://t.co/U4QQlLCx4Z 3rd party study: https://t.co/WhlaicgcXV Pfizer + influenza administered at the same time: https://t.co/ZtXGfwGgp0
@kerry_echo @RenzTom @truplistic 1. Abu-Raddad LJ, Chemaitelly H, Bertollini R, National Study Group for COVID-19 Vaccination. Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar. N Engl J Med 2022; 386:799.
@Lfthndjoshua @PatrioticPizzas @DrNeilStone 1. Abu-Raddad LJ, Chemaitelly H, Bertollini R, National Study Group for COVID-19 Vaccination. Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar. N Engl J Med 2022; 386:799.
@BobRoss54314105 @Skypso1 @HilaryGeraghty @Mainly_Aiming @liz_churchill10 1. Abu-Raddad LJ, Chemaitelly H, Bertollini R, National Study Group for COVID-19 Vaccination. Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar. N Engl J Med 2022; 386:799.
@picker_six1253 @AndyGJBurge @ABridgen 1. Abu-Raddad LJ, Chemaitelly H, Bertollini R, National Study Group for COVID-19 Vaccination. Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar. N Engl J Med 2022; 386:799.
@Kevin_McKernan @CrostyGa @JesslovesMJK 1. Abu-Raddad LJ, Chemaitelly H, Bertollini R, National Study Group for COVID-19 Vaccination. Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar. N Engl J Med 2022; 386:799.
@TheCIVICSc @2022ghost1 @JohntheLyricist 1. Abu-Raddad LJ, Chemaitelly H, Bertollini R, National Study Group for COVID-19 Vaccination. Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar. N Engl J Med 2022; 386:799.
@ThatGuy32519351 @ecocentrism1 @Wejolyn 1. Abu-Raddad LJ, Chemaitelly H, Bertollini R, National Study Group for COVID-19 Vaccination. Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar. N Engl J Med 2022; 386:799.
@FiveTimesAugust 1. Abu-Raddad LJ, Chemaitelly H, Bertollini R, National Study Group for COVID-19 Vaccination. Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar. N Engl J Med 2022; 386:799.
@RobH013 @GMarshRN @AlastairMcA30 1. Abu-Raddad LJ, Chemaitelly H, Bertollini R, National Study Group for COVID-19 Vaccination. Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar. N Engl J Med 2022; 386:799.
@HeatMisersCave @hirshdeborah1 @SenRandPaul @GStempky 1. Abu-Raddad LJ, Chemaitelly H, Bertollini R, National Study Group for COVID-19 Vaccination. Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar. N Engl J Med 2022; 386:799.
2/ ... ES SU DECISIÓN. EL FUNDAMENTO CIENTIFICO PARA COLOCAR TERCERA Y CUARTA DOSIS, ADEMAS DE EVIDENCIA. Las vacunas que con el tiempo han demostrado más eficacia son las ARNm es decir Pfizer y Moderna : en este estudio se compararon 193,000 personas https://t.co/g9V83LTugD
@rasc_angel17 @GeoeWatchDebunk @MartinKulldorff https://t.co/l5nhQimqSX
@thereal_truther 2-Dose Pfizer is only 80% effective at 30 days. Less than 20% by 6 months, with rapid fall-off from there. You know this with certainty. But lying for what reason? This is the data out of Qatar, same as in US, UK, Denmark, Sweden, Iceland, Netherlands. https://t.co/ibFTPeOrjJ
RT @HowardRoarkjr: ⬇️
⬇️
@JelleVanluchene @Awkward23241701 @WearyDJ @michel_bakkum @MarkTwaarde10 @ThomasInLeiden @VermeulenBart @DCSZ14 @vpknerd @Lauwke3 @PostvanFenna @DirkvanLinth @michielvan_b @Hnschen10 @Marc_Veld @Dieren_Doc @VaxxDoc Jij stelt je in deze op als de juf. Jij beweert doorlopend met vage termen dat data niet klopt maar kunt het niet bewijzen. Toon maar aan dat deze data niet klopt. https://t.co/aQvKMvClbx
@JelleVanluchene @Awkward23241701 @WearyDJ @michel_bakkum @MarkTwaarde10 @ThomasInLeiden @VermeulenBart @DCSZ14 @vpknerd @Lauwke3 @PostvanFenna @DirkvanLinth @michielvan_b @Hnschen10 @Marc_Veld @Dieren_Doc @VaxxDoc https://t.co/aQvKMvCT15
@LetsTimo @mvabercron @HGMaassen https://t.co/wQfFGtDVWe
@MuckelMom @fisiflo @Duerrelafett @Anwalt_Jun Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar | NEJM https://t.co/Aukhg4cFdC Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM https://t.co/6JO9DuVo6r
@BerlinerNord @ceeceeclaudia @K_G_Andersen Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar | NEJM https://t.co/Aukhg4cFdC Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM https://t.co/6JO9DuVo6r
@TakeoYasha @Hosenmaus1 @Karl_Lauterbach Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar | NEJM https://t.co/Aukhg4cFdC Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM https://t.co/6JO9DuVo6r
@FrauT18 @TidesSilverfal @Ellerbr06014411 @____Jeannette @MarcoBuschmann @Karl_Lauterbach Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar | NEJM https://t.co/Aukhg4cFdC Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM https://t.co/6JO9DuVo6r
@chr_stg @Hosenmaus1 @Karl_Lauterbach Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar | NEJM https://t.co/Aukhg3V3P2 Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM https://t.co/6JO9DvcYXZ
@TidesSilverfal @Risikofamilie @Ellerbr06014411 @____Jeannette @MarcoBuschmann @Karl_Lauterbach @IdiotenD Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar | NEJM https://t.co/Aukhg4cFdC Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM https://t.co/6JO9DuVo6r
@Risikofamilie @TidesSilverfal @Ellerbr06014411 @____Jeannette @MarcoBuschmann @Karl_Lauterbach @IdiotenD Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar | NEJM https://t.co/Aukhg4cFdC Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM https://t.co/6JO9DuVo6r
@Tzerberus1 @AnnasBackwelt @____Jeannette @Karl_Lauterbach @MarcoBuschmann Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM https://t.co/6JO9DuVo6r
https://t.co/kQmzYnXGsy
なんぼでも科学的根拠ありますけど 宮沢孝幸の主張には科学的根拠はないですけどね #デマ #1730万研究費不正 https://t.co/YE6rwB6h5E https://t.co/9L0mGSNIoT https://t.co/DVovp7cpHX https://t.co/vJPeBzB21B https://t.co/9UspsGOY0T https://t.co/9aOgX2glPD https://t.co/aRiooQ1xjV https://t.co/iMZhGscjXw
RT @balkraix: @Inconforme75 @BeatrizTalegon 173-https://t.co/httZqzdKfv 174-https://t.co/k1V1EmHScu 175-https://t.co/i8ziMTNoAF 176-https:/…
@BredeBS La moderna tiene un mejor efecto que la pfizer. https://t.co/gQa20k6SyD https://t.co/CsJ589NXUI
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
@Inconforme75 @BeatrizTalegon 173-https://t.co/httZqzdKfv 174-https://t.co/k1V1EmHScu 175-https://t.co/i8ziMTNoAF 176-https://t.co/gPONicElAy 177-https://t.co/EQr5G6bdwN 178-https://t.co/CpJgcG5fJf 179-https://t.co/1LE0in6bYz 180-https://t.co/2oRZE0z9Ea! 181-https://t.co/ghpODTbWP8 182-https://t.co/FDHnzNPfO3
@Bebert701 @TheFrankmanMN @mcfunny @xx202Qxx @F250Roush @ChrisJohnsonMD @JonathanHannah @ArtysHouse @carlsmythe @JCDeardeuff @SassyGirlD1 @JoeCoyle101 @LWSmith15 @fowlerfam1 @TheCrystalBrian @sammk1964 @noescape2021 @SkepticSplinter @groin_hammer @MartinTurnbul19 @andylumm @TwoCoconutHusks @moy_barry @temple_surly @BurgerLab12 @SwaledaleMutton @RTheatheist @wjack76995 @TierraHenson @JustPlaying2Win @Noel82002324 @Shared_facts @MRobovsky @pawley_robert @Chris_F_Carson @Ipdailyok @ghoppe @ADevotedYogi @OceanAteMyPhone @DrJoeMcCarthy @frugalsues @ShawnWo78307528 @Hashgraphian @claudeddaniel @thatsnotmine125 @BuzzKent1776 @barryjohnreid21 @rw_christian @cappsie @Kathmarval Sure. Here’s a study that came out a few weeks ago from Qatar. Almost 80% of the population is vaccinated so it’s a population about 10x larger than your study. 1 person died vs 5 in yours, 10 were hospitalized vs 82 in yo
RT @Laith_AbuRaddad: Our study published in NEJM showed that Moderna and Pfizer vaccines had similar patterns of build-up of protection aft…
RT @Laith_AbuRaddad: Our study published in NEJM showed that Moderna and Pfizer vaccines had similar patterns of build-up of protection aft…
A recent large study in Qatar found higher vaccine effectiveness with Moderna compared to Pfizer against severe COVID-19 https://t.co/fsMtDaZ1ig 10/
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar https://t.co/OrSlZLvSGr
RT @dimgrr: NIeuwe studie in NEJM: "At approximately 90 days after the second dose, during a period of a low incidence of infection in Qata…
RT @One_Health_In: "Vaccination with the @moderna_tx vaccine was associated with a lower incidence of #COVID19 breakthrough infection than…
"Vaccination with the @moderna_tx vaccine was associated with a lower incidence of #COVID19 breakthrough infection than vaccination with the @pfizer vaccine" - Study sample size: 192,123 * 2 - Study location: Qatar #epitwitter @NEJM https://t.co/ww2ocGrPr7
RT @Laith_AbuRaddad: Our study published in NEJM showed that Moderna and Pfizer vaccines had similar patterns of build-up of protection aft…
RT @Laith_AbuRaddad: Our study published in NEJM showed that Moderna and Pfizer vaccines had similar patterns of build-up of protection aft…
RT @boticariors:
RT @boticariors:
RT @boticariors:
RT @Laith_AbuRaddad: Our study published in NEJM showed that Moderna and Pfizer vaccines had similar patterns of build-up of protection aft…
RT @Laith_AbuRaddad: Our study published in NEJM showed that Moderna and Pfizer vaccines had similar patterns of build-up of protection aft…
RT @boticariors:
RT @Laith_AbuRaddad: Our study published in NEJM showed that Moderna and Pfizer vaccines had similar patterns of build-up of protection aft…
RT @boticariors:
RT @boticariors:
RT @boticariors:
RT @boticariors:
RT @boticariors:
RT @boticariors:
https://t.co/vfZ1oysIEs
https://t.co/XKxR73jrrU
RT @EricTopol: The Qatar comparison of 2-shot mRNA vaccines (matched >192,000 people) shows superiority of Moderna over Pfizer for less bre…
A study in Qatar shows that #Moderna is slightly more effective than #Pfizer https://t.co/pCc7aJUeTq #COVID19 #OmicronVariant #Qatar
RT @EricTopol: The Qatar comparison of 2-shot mRNA vaccines (matched >192,000 people) shows superiority of Moderna over Pfizer for less bre…
RT @EricTopol: The Qatar comparison of 2-shot mRNA vaccines (matched >192,000 people) shows superiority of Moderna over Pfizer for less bre…
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM https://t.co/8GRbbLrMVw
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @EricTopol: The Qatar comparison of 2-shot mRNA vaccines (matched >192,000 people) shows superiority of Moderna over Pfizer for less bre…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar https://t.co/YvNFdBFJdU
RT @NEJM: In two matched retrospective cohort studies comparing BNT162b2 and mRNA-1273, both were highly effective at preventing hospitaliz…
RT @EricTopol: The Qatar comparison of 2-shot mRNA vaccines (matched >192,000 people) shows superiority of Moderna over Pfizer for less bre…
#Effectiveness of #mRNA -1273 and BNT162b2 #vaccines in Qatar | NEJM #vaccine #vaccination #VaccinesWork #VaccinesSaveLives https://t.co/61PC3Mi0SG
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @EricTopol: The Qatar comparison of 2-shot mRNA vaccines (matched >192,000 people) shows superiority of Moderna over Pfizer for less bre…
RT @EricTopol: The Qatar comparison of 2-shot mRNA vaccines (matched >192,000 people) shows superiority of Moderna over Pfizer for less bre…
RT @EricTopol: The Qatar comparison of 2-shot mRNA vaccines (matched >192,000 people) shows superiority of Moderna over Pfizer for less bre…
RT @NEJM: In two matched retrospective cohort studies comparing BNT162b2 and mRNA-1273, both were highly effective at preventing hospitaliz…
RT @EricTopol: The Qatar comparison of 2-shot mRNA vaccines (matched >192,000 people) shows superiority of Moderna over Pfizer for less bre…
A populational-based retrospective cohort study in Qatar showed a reduced risk of Covid-19 breakthrough infections with the Moderna vs. the Pfizer–BioNTech vaccine. – via @NEJM https://t.co/ha2NSta0fK
RT @EricTopol: The Qatar comparison of 2-shot mRNA vaccines (matched >192,000 people) shows superiority of Moderna over Pfizer for less bre…
RT @EricTopol: The Qatar comparison of 2-shot mRNA vaccines (matched >192,000 people) shows superiority of Moderna over Pfizer for less bre…
Moderna or Pfizer? https://t.co/nlQ2wxWUjG
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @EricTopol: The Qatar comparison of 2-shot mRNA vaccines (matched >192,000 people) shows superiority of Moderna over Pfizer for less bre…
RT @NEJM: In two matched retrospective cohort studies comparing BNT162b2 and mRNA-1273, both were highly effective at preventing hospitaliz…
RT @EricTopol: The Qatar comparison of 2-shot mRNA vaccines (matched >192,000 people) shows superiority of Moderna over Pfizer for less bre…
RT @EricTopol: The Qatar comparison of 2-shot mRNA vaccines (matched >192,000 people) shows superiority of Moderna over Pfizer for less bre…
RT @EricTopol: The Qatar comparison of 2-shot mRNA vaccines (matched >192,000 people) shows superiority of Moderna over Pfizer for less bre…
RT @NEJM: In two matched retrospective cohort studies comparing BNT162b2 and mRNA-1273, both were highly effective at preventing hospitaliz…
RT @EricTopol: The Qatar comparison of 2-shot mRNA vaccines (matched >192,000 people) shows superiority of Moderna over Pfizer for less bre…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @EricTopol: The Qatar comparison of 2-shot mRNA vaccines (matched >192,000 people) shows superiority of Moderna over Pfizer for less bre…
RT @EricTopol: The Qatar comparison of 2-shot mRNA vaccines (matched >192,000 people) shows superiority of Moderna over Pfizer for less bre…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @NEJM: In two matched retrospective cohort studies comparing BNT162b2 and mRNA-1273, both were highly effective at preventing hospitaliz…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
RT @carpe_diem0820: モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2…
モデルナ及びファイザーのmRNAワクチンは2回接種から3カ月後から感染予防効果が漸減も、重症化予防効果は一定程度維持 効果はモデルナがファイザーより高い結果 Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar https://t.co/4sWDfYEKBs https://t.co/7FnJHvvGPp
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM https://t.co/ZlUwjGbzmU
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM https://t.co/JbQuykj6rv
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar https://t.co/2SxOSSwNTV
The effectiveness of mRNA-1273 and BNT162b2 vaccines in Qatar https://t.co/HVXD85TZYk
עבודה מקטאר המשווה יעילות בין חיסון פייזר לבין חיסון מודרנה. Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM https://t.co/PUfyWO9aRk
約20万人を対象としたmRNAワクチン接種後のブレイクスルー感染を調べたカタールの後ろ向きコホート研究 2022.1.19 ファイザー-ビオンテックとモデルナでは,前者のブレイクスルー感染の方が多かった. Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM https://t.co/7HeWUmxWh8
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM https://t.co/YjIN36Oscl
RT @JohnHRandall1: Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM https://t.co/H5UFM68Z7B
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM https://t.co/H5UFM68Z7B
RT @barriere_dr: Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM Avantage Moderna https://t.co/8ElG5eBJ2B
RT @barriere_dr: Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM Avantage Moderna https://t.co/8ElG5eBJ2B
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM Avantage Moderna https://t.co/8ElG5eBJ2B
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM https://t.co/ON04FhOmvH
preprint now out on NEJM Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar $PFE $BNTX $MRNA https://t.co/as69D6ZO9Q
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | DOI: 10.1056/NEJMc2117933 · No photo description available. WHATSAPP. Neumólogo - Dr. Pavel ...
... , 385(19), 187-189. DOI: 10.1056/NEJMc2117933. cdc.gov. Clinical Guidance for COVID- 19 Vaccination | CDC. 8 mos. 4. Михаил Медведев. Я ...
... 10.1056... 0 0 · BenX 11:50 20.februar 2024. prijavi. 7. Effectiveness ... NEJMc2117933 https://www.nejm.org/doi/pdf/10.1056/NEJMoa2203965 ...
https://doi.org/10.1056/NEJMc2117933 PMID: 35045222. 41. Patalon T, Saciuk Y, Peretz A, Perez G, Lurie Y, Maor Y, et al. Waning effectiveness ...
doi: 10.1056/NEJMc2117933. pmid:35045222. 41. Patalon T, Saciuk Y, Peretz A, Perez G, Lurie Y, Maor Y, et al. Waning effectiveness of the ...
org/doi/full/10.1056/NEJMc2117933 Tentang Bill Gates: https://www.nytimes. com/2020/11/23/world/bill-gates- vaccine-coronavirus.html. nejm ...
New England Journal of Medicine Feb, 2022 DOI: 10.1056/NEJMc2117933 Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar. Plus sur le ...
org/doi/full/10.1056/NEJMc2117933 #อบอุ่น #เชี่ยวชาญ #โรงพยาบาลรามคำแหง · No photo description available. MESSENGER. โรงพยาบาลรามคำแหง ...
org/doi/full/10.1056/NEJMc2117933 #อบอุ่น #เชี่ยวชาญ #โรงพยาบาลรามคำแหง. Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM.
M無
A
EJ
DM
B
IK
V
LK
RJ
K
J
M
HJ
M
A
P
F
Aˎ
M
そG
R
F
ち
夢こ
つ
LK
AB
HC
KY
EG
C
E
OI
Hا
WR
W
LS
M
HA
AN
MP
FA
CN
EM
JL
AC
V
MM
A
KG
MC
AH
SD
D
ｺ
VR
NB
ぷ
TH
B
G
TH
乙
Sシ
K
DC
AF
IT
YS
DF
A
MD
AP
YP
DP
WM
CD
SM
마
M
フ
M
ま
A
さT
ま
ま時
AS
TK
新B
窓
紅
法
つゴ
レ
義Y
夜
そ
鵞
T智
まO
S精
たぢ
シ
全
ま
TX
TL
ML
あ
ノ
知公
IS
C
MT
JS
F
KP
SF
L
JM
BD